DeepDx® Prostate – CNB
AI software for prostate cancer
Description
DeepDx® Prostate is a clinically validated and CE-marked AI diagnostic support software for prostate cancer. The software analyzes digitized slide images of Hematoxylin & Eosin (H&E) stained prostate specimens to detect and localize areas of interest. These areas of interest are detected based on their severity in accordance with the Gleason Scoring System.
Key Features
-
01
Approved by Korea MFDS, and CE marked
-
02
Procedure Type
Needle biopsy, TURP and Prostatectomy (Coming Soon)
-
03
Extensively Tested
700k+ cores analyzed
-
04
Versatile Deployment
Cloud & On-Premise
-
01
AI-based diagnostics support
AI analysis includes ROI detection, Gleason scores, grade group, and quantification of important matrix.
-
02
Fast and Accurate
It takes 30 seconds to run the AI analysis (per core), and improves accuracy with 99% sensitivity and 97% specificity.
-
03
Research-Based
DeepDx® Prostate validation studies were published in prestigious peer-reviewed medical journals including Cancers and npj Digital Medicine.
-
04
Consistency
DeepDx® Prostate generates consistency as a diagnostics support software.
Key Functions & Featuress
-
Colored Overlays
DeepDx® Prostate generates three different colored overlays based on the Gleason patterns 3, 4, and 5.
-
Tumor & Pattern Quantification
The proportions of each Gleason pattern out of the total tumor area and tumor-to-tissue ratios are automatically quantified.
-
Real-time Modification
Quantitative metrics such as tumor-to-tissue ratios and Gleason pattern ratios are recalculated in real time as annotations are made.
-
Annotation Tools
Annotation tools allow the user to modify the AI analysis results. Automatic measurements of total tissue and total tumor lengths are also generated.